New Once-Monthly Drug Cuts Cholesterol

Monday, 17 Mar 2014 12:35 PM

 

  Comment  |
   Contact  |
  Print   |
    A   A  
  Copy Shortlink

Amgen Inc said on Monday its experimental new type of cholesterol fighter met the primary goal of a late-stage trial by significantly cutting "bad" LDL cholesterol among patients with a genetic tendency towards very high levels of the artery clogging fat.
 
Amgen said patients given its injectable drug evolocumab once a month on top of standard daily statin treatments showed "clinically meaningful" improvement compared to statins alone after 12 weeks of treatment.
 
Evolocumab works by blocking PCSK9, a naturally occurring protein that keeps LDL levels elevated in the bloodstream. Other drugmakers, including Pfizer Inc and a partnership between Regeneron Inc and Sanofi, are racing with Amgen to complete trials of potentially lucrative anti-PCSK9 antibodies.
 
ALERT: 4 Things You'll Feel Before a Heart Attack


© 2014 Thomson/Reuters. All rights reserved.

  Comment  |
   Contact  |
  Print   |
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Can the Blood of Ebola Survivors Create a Cure?

Monday, 22 Dec 2014 08:05 AM

For months,Vanderbilt University researcher Dr. James Crowe has been desperately seeking access to the blood of U.S. Ebo . . .

CDC Report Reveals How Measles Spreads at Airports

Sunday, 21 Dec 2014 10:23 AM

Traveling through the same U.S. airport gate, one infected passenger transmitted the measles virus to three others withi . . .

Food Pesticide Residue Nothing to Worry About: USDA

Saturday, 20 Dec 2014 10:26 AM

More than half of food tested by the U.S. government for pesticide residues last year showed detectable levels of pestic . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved